Michael E. Rothe
Robert Rössle Str. 10, B55
Berlin, BE 13125, Germany
Berlin, BE 13125, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 195 publications
Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Journal: JCO precision oncology
Published: July 15, 2026
Pertuzumab and Trastuzumab in Patients With ERBB2/3-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry Study.
Journal: JCO precision oncology
Published: April 30, 2026
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With High Tumor Mutation Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.
Journal: JCO precision oncology
Published: April 30, 2026
Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Journal: JCO precision oncology
Published: April 22, 2026
Selective intraoperative cholangiography: A retrospective single-centre analysis compared with national data and implications for surgical training.
Journal: Langenbeck's archives of surgery
Published: April 04, 2026
SAGA-Q: Gene Expression Differences Enable Detection of Retroviral Vectors with Mutagenic Potential.
SAGA-Q: Gene Expression Differences Enable Detection of Retroviral Vectors with Mutagenic Potential.
Journal: Human gene therapy
Published: January 30, 2026
Septin7 is essential in early hematopoiesis, but redundant at later stages.
Journal: Life science alliance
Published: January 26, 2026
Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Journal: JCO precision oncology
Published: January 15, 2026
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.
Journal: Obstetrical & gynecological survey
Published: December 30, 2025
Reactivity of mammalian lipoxygenases (ALOX isoforms) with phospholipids, biomembranes and lipoproteins.
Journal: Communications biology
Published: December 05, 2025
Ex vivo long-term expansion of human hematopoietic stem and progenitor cells as a tool for modeling vector integration sites and clonality.
Journal: Journal of translational medicine
Published: October 29, 2025
Olaparib in Patients With Solid Tumors With BRCA1/2 Alterations: Results From The Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Journal: JCO precision oncology
Published: October 16, 2025
Last Updated: 09/26/2026